Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06253182 · ClinicalTrials.gov registry record · NA

Psychosexual Educational Partners Program (PEPP)

A NA study of Breast Cancer and Gynecologic Cancer, sponsored by The University of Tennessee, Knoxville.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06253182: Active NA study of Breast Cancer and Gynecologic Cancer, sponsored by The University of Tennessee, Knoxville.

NCT06253182 is a NA study of Breast Cancer and Gynecologic Cancer that is active but no longer recruiting, run by The University of Tennessee, Knoxville. The registered enrollment target is 60 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06253182, a NA study of Breast Cancer and Gynecologic Cancer, is active but no longer recruiting, sponsored by The University of Tennessee, Knoxville.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to compare two Psychosexual Educational programs for women who have completed treatment for breast or gynecological cancer and their partners in preparation for a well-powered phase III study. The investigators plan to enroll 30 dyads in a 2-arm pilot randomized controlled trial (RCT). The primary aim will be to assess the preliminary efficacy of the Psychosexual Educational Partners Program (PEPP) on sexual communication.

Primary Outcome

The preliminary efficacy of the revised PEPP intervention on sexual communication among dyads. The DSC is a single-dimensional 13-item scale that measures sexual communication between partners on a 4-point Likert scale, disagree strongly to agree strongly. Possible scores range from 13-52 with higher scores indicating better sexual communication.

Interventions

  • BEHAVIORAL Self-Guided PEPP Intervention Workbook
  • BEHAVIORAL Self-Guided PEPP Education Workbook

Study Locations (1)

Tennessee

  • University of Tennessee Knoxville - Knoxville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-04-02
Est. Completion 2025-09-30
Phase NA

What the registry record for NCT06253182 still lists

NCT06253182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Self-Guided PEPP Intervention Workbook is the first listed.

NCT06253182 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT06253182 about?

NCT06253182 is a clinical study titled "Psychosexual Educational Partners Program (PEPP)". The purpose of this study is to compare two Psychosexual Educational programs for women who have completed treatment for breast or gynecological cancer and their partners in preparation for a well-powered phase III study. The investigators plan to enroll 30 dyads in a 2-arm pilot randomized controll...

What is the current status of trial NCT06253182?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-04-02. Estimated completion is 2025-09-30.

What conditions does trial NCT06253182 study?

This clinical trial studies the following conditions: Breast Cancer, Gynecologic Cancer, Sexual Dysfunction, Partner Communication.

What interventions are being tested in trial NCT06253182?

The interventions under investigation include: Self-Guided PEPP Intervention Workbook (BEHAVIORAL), Self-Guided PEPP Education Workbook (BEHAVIORAL).

Who is sponsoring clinical trial NCT06253182?

This trial is sponsored by The University of Tennessee, Knoxville, which has 81 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06253182 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06253182's enrollment target sits among peer trials

60 736th of 1224 higher than 468 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06253182, the US trial registry maintained by the National Library of Medicine. NCT06253182 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.